Chemotherapy-induced CDA expression renders resistant non-small cell lung cancer cells sensitive to 5'-deoxy-5-fluorocytidine (5'-DFCR)
CONCLUSIONS: Chemotherapy increases CDA and TYMP expression thereby rendering resistant lung cancer cells susceptible to subsequent 5'-DFCR treatment.PMID:33874986 | DOI:10.1186/s13046-021-01938-2
Source: Clinical Lung Cancer - Category: Cancer & Oncology Authors: Yanyun Gao Philipp Zens Min Su Camila Anna Gemperli Haitang Yang Haibin Deng Zhang Yang Duo Xu Sean R R Hall Sabina Berezowska Patrick Dorn Ren-Wang Peng Ralph Alexander Schmid Wenxiang Wang Thomas Michael Marti Source Type: research
More News: Addiction | Alimta | Cancer | Cancer & Oncology | Chemotherapy | Lung Cancer | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Non-Small Cell Lung Cancer | Study | Xeloda